197 related articles for article (PubMed ID: 5099124)
1. Treatment of severe hypertension with Catapres (St 155). A comparative study of the effect of catapres and methyldopa in a series of hypertensive outpatients (WHO stage 3).
Becker-Christensen F; Bang HO; Ditzel J
Acta Med Scand; 1971; 190(1-2):21-6. PubMed ID: 5099124
[No Abstract] [Full Text] [Related]
2. [Treatment of severe hypertension with Catapresan. A comparative study of the effects of Catapresan and methyldopa on ambulant hypertensive patients].
Becker-Christensen F; Bang HO; Ditzel J
Ugeskr Laeger; 1970 Dec; 132(49):2331-6. PubMed ID: 5488234
[No Abstract] [Full Text] [Related]
3. A comparison of alpha-methyldopa (aldomet) and ST155 (catapres) in the treatment of hypertension.
Seedat YK; Vawda EI; Mitha S; Ramasar R
S Afr Med J; 1970 Mar; 44(10):300-1. PubMed ID: 5443298
[No Abstract] [Full Text] [Related]
4. Hypotensive action and side effects of clonidine-chlorthalidone and methyldopa-chlorthalidone in treatment of hypertension.
Amery A; Verstraete M; Bossaert H; Verstreken G
Br Med J; 1970 Nov; 4(5732):392-5. PubMed ID: 4921284
[TBL] [Abstract][Full Text] [Related]
5. Comparison of clonidine and methyldopa in hypertensive patients receiving a diuretic. A double-blind crossover study.
Mroczek WJ; Leibel BA; Finnerty FA
Am J Cardiol; 1972 May; 29(5):712-7. PubMed ID: 4553738
[No Abstract] [Full Text] [Related]
6. Clonidine versus methyldopa. A double blind cross-over study comparing side effects of clonidine and methyldopa administered together with chlorthalidone at a dosage producing the same blood pressure lowering effect.
Amery AK; Bossaert H; Fagard RH; Verstraete M
Acta Cardiol; 1972; 21(1):82-99. PubMed ID: 4553878
[No Abstract] [Full Text] [Related]
7. Pharmacodynamic effects of a new antihypertensive drug, Catapres (ST-155).
Onesti G; Schwartz AB; Kim KE; Swartz C; Brest AN
Circulation; 1969 Feb; 39(2):219-28. PubMed ID: 4884576
[No Abstract] [Full Text] [Related]
8. [Effect of prolonged treatment with 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on renal hemodynamics in arterial hypertension].
Ludwig H
Arzneimittelforschung; 1968 May; 18(5):600-4. PubMed ID: 5755891
[No Abstract] [Full Text] [Related]
9. A comparison of chlorthalidone-reserpine and hydrochlorothiazide-methyldopa as step 2 therapy for hypertension.
Channick BJ; Kessler WB; Marks AD; Adlin EV
Clin Ther; 1981; 4(3):175-83. PubMed ID: 7307035
[TBL] [Abstract][Full Text] [Related]
10. Effects of clonidin and chlorthalidone on blood pressure and glucose tolerance in hypertensive patients.
Sung PK; Samet P; Yeh BK
Curr Ther Res Clin Exp; 1971 May; 13(5):280-5. PubMed ID: 4998390
[No Abstract] [Full Text] [Related]
11. [Controllable hypertension therapy with Tadip].
Schütz E
Med Klin; 1971 Jan; 66(4):121-6. PubMed ID: 5546736
[No Abstract] [Full Text] [Related]
12. A comparative study of alprenolol and alpha-methyldopa respectively in combination with chlorthalidone in hypertension.
Tuomilehto J; Puska P; Mustaniemi H
Acta Med Scand Suppl; 1974; 554():47-54. PubMed ID: 4593673
[No Abstract] [Full Text] [Related]
13. Methyldopa: single daily dose versus multiple daily dose.
Yang C; Gurwich E; Kanada S; Nascimento L
Clin Ther; 1982; 4(5):395-401. PubMed ID: 7039841
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
Karachalios GN
Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment of hypertension with methyldopa. VIII. Overview.
Itskovitz HD
J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S120-7. PubMed ID: 6172668
[TBL] [Abstract][Full Text] [Related]
16. [A comparative evaluation of metoprolol and methyldopa in hypertension therapy (author's transl)].
Muiesan G; Agabiti-Rosei E; Buoninconti R; Carotti A; Fariello R; Innocenti P; Solinas E; Toso M; Motolese M
G Ital Cardiol; 1980; 10(11):1482-90. PubMed ID: 7202896
[TBL] [Abstract][Full Text] [Related]
17. Comparative antihypertensive effects of guanabenz and methyldopa.
Walker BR; Deitch MW; Schneider BE; Hare LE
Clin Ther; 1981; 4(4):275-84. PubMed ID: 7332915
[TBL] [Abstract][Full Text] [Related]
18. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
19. Clonidine (Catapres): a new antihypertensive agent.
Khan A; Camel G; Perry HM
Curr Ther Res Clin Exp; 1970 Jan; 12(1):10-8. PubMed ID: 4984047
[No Abstract] [Full Text] [Related]
20. Comparison of clonidine and methyldopa on blood pressure and side effects in hypertensive patients.
Putzeys MR; Hoobler SW
Am Heart J; 1972 Apr; 83(4):464-8. PubMed ID: 5041833
[No Abstract] [Full Text] [Related]
[Next] [New Search]
